tiprankstipranks
Tectonic Therapeutic Inc (TECX)
NASDAQ:TECX
US Market
TECX
Tectonic Therapeutic
RESEARCH TOOLSreports
Want to see TECX full AI Analyst Report?

Tectonic Therapeutic (TECX) Stock News & Sentiment

659 Followers
Analyst Reaffirms Buy on Tectonic Therapeutic, Lifts Price Target to $88 on TX-45 Clinical Momentum and Expanded Market Opportunity
Premium
Ratings
Analyst Reaffirms Buy on Tectonic Therapeutic, Lifts Price Target to $88 on TX-45 Clinical Momentum and Expanded Market Opportunity
13d ago
TECX
Tyler Van Buren Reiterates Buy on Tectonic as Advancing TX45 Program, Expanded Pipeline, and Strong Cash Runway Support Favorable Long-Term Risk‑Reward
Premium
Ratings
Tyler Van Buren Reiterates Buy on Tectonic as Advancing TX45 Program, Expanded Pipeline, and Strong Cash Runway Support Favorable Long-Term Risk‑Reward
14d ago
TECX
Tectonic Therapeutic Adds Veteran Banker to Board
Premium
Company Announcements
Tectonic Therapeutic Adds Veteran Banker to Board
28d ago
8K
TECX
Tectonic Therapeutic: Buy Rating on De‑Risked TX‑45 Phase 2 Program, Emerging TX2100 Pipeline, and Sufficient Cash Runway to 2026 Data Catalysts
Premium
Ratings
Tectonic Therapeutic: Buy Rating on De‑Risked TX‑45 Phase 2 Program, Emerging TX2100 Pipeline, and Sufficient Cash Runway to 2026 Data Catalysts
3M ago
TECX
Tectonic Therapeutic Announces Leadership Transition and New Chair
Premium
Company Announcements
Tectonic Therapeutic Announces Leadership Transition and New Chair
3M ago
8K
TECX
Buy Rating on Tectonic: Differentiated TX45 Strategy, Favorable PK Profile, and Sufficient Cash Runway to Phase 2 Readouts
Premium
Ratings
Buy Rating on Tectonic: Differentiated TX45 Strategy, Favorable PK Profile, and Sufficient Cash Runway to Phase 2 Readouts
3M ago
TECX
Positive Outlook for Tectonic Therapeutic: Buy Rating Supported by Strategic Focus and Promising Trial Results
Premium
Ratings
Positive Outlook for Tectonic Therapeutic: Buy Rating Supported by Strategic Focus and Promising Trial Results
6M ago
TECX
More TECX News >

TECX News on the Web

Analysts Have Conflicting Sentiments on These Healthcare Companies: Tectonic Therapeutic (TECX) and Urogen Pharma (URGN)
TipRanks News
Neutral
LifeSci Capital Sticks to Its Buy Rating for Tectonic Therapeutic (TECX)
TipRanks News
Bullish
Oppenheimer Sticks to Its Buy Rating for Tectonic Therapeutic (TECX)
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: Tectonic Therapeutic (TECX) and LENZ Therapeutics (LENZ)
TipRanks News
Bullish
Truist Financial Sticks to Its Buy Rating for Tectonic Therapeutic (TECX)
TipRanks News
Bullish
Tectonic Therapeutic (TECX) Gets a Buy from Wells Fargo
TipRanks News
Bullish
LifeSci Capital Remains a Buy on Tectonic Therapeutic (TECX)
TipRanks News
Bullish
Piper Sandler Sticks to Its Buy Rating for Tectonic Therapeutic (TECX)
TipRanks News
Bullish

News Score - Last 7 Days

Very Positive
TECX
Sector Average
Media Buzz
This Week3 articles
Weekly Average2.75 articles
News Sentiment
This Week99%
Sector Average77%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is TECX’s Media Buzz Sentiment?
3 articles about TECX were published this week. In an average week, 2.75 articles are published.
    What is TECX’s weekly average amount of articles?
    In an average week, 2.75 articles about TECX are published.
      What is TECX’s News Sentiment?
      99% of articles about TECX were positive this week, compared to its sector average of 77%.
        Healthcare Stocks that are Trending in the News
        GOSSGossamer Bio
        RLAYRelay Therapeutics
        IMVTImmunovant
        ROIVRoivant Sciences
        PROKProKidney
        Showing the stocks with the most bullish news sentiment over the past week